Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes
- PMID: 17491678
- PMCID: PMC1783542
- DOI: 10.1900/RDS.2004.1.145
Spotlight on ethnomedicine: usability of Sutherlandia frutescens in the treatment of diabetes
Similar articles
-
Sutherlandia frutescens prevents changes in diabetes-related gene expression in a fructose-induced insulin resistant cell model.J Ethnopharmacol. 2013 Mar 27;146(2):482-9. doi: 10.1016/j.jep.2013.01.008. Epub 2013 Feb 1. J Ethnopharmacol. 2013. PMID: 23376105
-
Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: implications for absorption and metabolism.J Pharm Pharm Sci. 2012;15(2):221-33. doi: 10.18433/j3ns3x. J Pharm Pharm Sci. 2012. PMID: 22579002
-
Anti-diabetic effects of Sutherlandia frutescens in Wistar rats fed a diabetogenic diet.J Ethnopharmacol. 2007 Jan 3;109(1):121-7. doi: 10.1016/j.jep.2006.07.012. Epub 2006 Jul 22. J Ethnopharmacol. 2007. PMID: 16939705
-
A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae).J Ethnopharmacol. 2008 Oct 28;119(3):620-9. doi: 10.1016/j.jep.2008.08.003. Epub 2008 Aug 9. J Ethnopharmacol. 2008. PMID: 18761068 Review.
-
Does Concurrent Use of Some Botanicals Interfere with Treatment of Tuberculosis?Neuromolecular Med. 2016 Sep;18(3):483-6. doi: 10.1007/s12017-016-8402-1. Epub 2016 May 7. Neuromolecular Med. 2016. PMID: 27155670 Free PMC article. Review.
Cited by
-
Effects of Sutherlandia frutescens extracts on normal T-lymphocytes in vitro.Afr J Tradit Complement Altern Med. 2011 Oct 2;9(1):73-80. eCollection 2012. Afr J Tradit Complement Altern Med. 2011. PMID: 23983323 Free PMC article.
-
The immunomodulatory effects of Sutherlandia frutescens extracts in human normal peripheral blood mononuclear cells.Afr J Tradit Complement Altern Med. 2012 Feb 13;9(3 Suppl):40-6. doi: 10.4314/ajtcam.v9i3s.6. eCollection 2012. Afr J Tradit Complement Altern Med. 2012. PMID: 23983354 Free PMC article.
-
The mutagenic and antimutagenic activity of Sutherlandia frutescens extracts and marker compounds.BMC Complement Altern Med. 2018 Mar 15;18(1):93. doi: 10.1186/s12906-018-2159-z. BMC Complement Altern Med. 2018. PMID: 29544492 Free PMC article.
-
Effect of short term and chronic administration of Sutherlandia frutescens on pharmacokinetics of nevirapine in rats.Int J Pharm. 2011 Jul 15;413(1-2):44-50. doi: 10.1016/j.ijpharm.2011.04.051. Epub 2011 Apr 23. Int J Pharm. 2011. PMID: 21545833 Free PMC article.
-
Evaluation of the Neuroprotective Potential of Sutherlandia frutescens in a Rotenone-Induced Rat Model of Parkinson's Disease.Behav Neurol. 2025 Mar 11;2025:6606560. doi: 10.1155/bn/6606560. eCollection 2025. Behav Neurol. 2025. PMID: 40224523 Free PMC article.
References
-
- Van Wyk BE, Van Oudtshoorn B, Gericke N. Medicinal plants of South Africa. 2nd edition. Briza Publications; Pretoria: 2002.
-
- Fernandes AC, Cromarty AD, Albrecht C, Jansen van Rensburg CE. The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol. 2004;95(1):1–5. - PubMed
-
- Tai J, Cheung S, Chan E, Hasman D. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. J Ethnopharmacology. 2004;93:9–19. - PubMed
-
- Ojewole JA. Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods Find Exp Clin Pharmacol. 2004;26(6):409–416. - PubMed
-
- Swaffar DS, Ang CY, Desai PB, Rosenthal GA. Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res. 1994;54(23):6045–6048. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources